Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide.

CONCLUSION: Low-dose CS combined with oral CTX treatment is possibly more effective than uncontrolled supportive care for IgAN patients with reduced renal function. The results need to be further confirmed by randomized controlled studies.
PMID: 32447619 [PubMed - as supplied by publisher]

Source: Journal of Nephrology - May 22, 2020 Category: Urology & Nephrology Authors: Ma F, Yang X, Zhou M, Bai M, Zhao L, Li L, Dong R, Liu C, Li R, Sun S Tags: J Nephrol Source Type: research